AI assistant
Sending…
MACROGENICS INC — Director's Dealing 2017
May 23, 2017
34129_dirs_2017-05-22_be629e11-ba33-4ed8-ad18-a81604c72457.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2017-05-18
Reporting Person: Peters Jeffrey Stuart (Acting General Counsel)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (right to buy) | $35.54 | 2025-07-27 | Common Stock (19800.0) | Direct | |
| Stock Option (right to buy) | $31.43 | 2025-12-18 | Common Stock (2542.0) | Direct | |
| Stock Option (right to buy) | $20.53 | 2027-02-15 | Common Stock (12000.0) | Direct |
Footnotes
F1: 12.5% of the options become exercisable 6 months after the date of grant and the remaining 87.5% shall vest in 14 substantially equal quarterly installments thereafter.
More from MACROGENICS INC
Declaration of Voting Results & Voting Rights Announcements
2026
May 20
Regulatory Filings
2026
May 13
Merger & Acquisition
2026
May 12
Proxy Solicitation & Information Statement
2026
Apr 8
Major Shareholding Notification
2026
Mar 27
Board/Management Information
2026
Mar 2
Regulatory Filings
2026
Feb 24
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18